18 results
Topical drug formulations, comparison and considerations

#pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
considerations #pharmacology ... #table #medications ... #comparison #drugs ... #treatment #pharmacotherapy ... #dermatology
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
with caution - e.g ... #pharmacology #comparison ... #treatment #medications ... #dosing #drugs ... #table #pharmacotherapy
Shock and Vasoactive Drugs 
1) Determine type and etiology of shock
 • Distributive: Sepsis, Anaphylaxis, Neurogenic
rupture, VSD, etc ... Arrhythmias / CHB ... inopressors #diagnosis ... #management #comparison ... #table
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
response to the drug ... management #algorithm #pharmacology ... #treatment #medications ... #table #pharmacotherapy ... #warfarin #dosing
Summary of Coagulation Deficiencies
Inherited:
 • Hemophilia A - Deficiency of Factor VIII
 • Hemophilia B -
Malabsorption (e.g ... celiac disease, CF ... Deficiencies #Summary #table ... #comparison #diagnosis ... #hematology #deficiency
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
: 33% • Treatment ... : Age>60, CKD, CHF ... : No • Treatment ... #diagnosis #comparison ... #table
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
INDICATION: Treatment ... oral suspension DOSING ... patients with CKD, HF ... ACE inhibitors, etc ... #Hyperkalemia #Pharmacology
Eosinophil Disorders Testing Algorithm
INDICATIONS FOR TESTING:
 • Peripheral blood eosinophilia/hypereosinophilia uncovered incidentally during medical evaluation or
uncovered incidentally during ... asthma, allergy, drug ... glucocorticoid treatment ... signs or symptoms (eg ... #Differential #diagnosis
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
exacerbations Drug ... Eosinophils < 100 Dosing ... : 250 mcg tablet ... recommendations for the treatment ... #Indications #Pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
ECG is vital while ... then be excreted using ... #table #foamed ... #heartfailure #chf ... icu #clinical #pharmacology